Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy

Ischaemic cardiomyopathy is the most common cause of heart failure and often coexists with diabetes mellitus which worsens patient symptom burden and outcomes. Yet, their combined effects are seldom investigated and are poorly understood. To uncover the influencing molecular signature defining ischaemic cardiomyopathy with diabetes, we performed multi-omic analyses of ischaemic and non-ischaemic cardiomyopathy with and without diabetes against healthy age-matched donors. Tissue was sourced from pre-mortem human left ventricular myocardium. Fatty acid transport and oxidation proteins were most down-regulated in ischaemic cardiomyopathy with diabetes relative to donors. However, the down-regulation of acylcarnitines, perilipin, and ketone body, amino acid and glucose metabolising proteins indicated lipid metabolism may not be entirely impaired. Oxidative phosphorylation, oxidative stress, myofibrosis, and cardiomyocyte cytoarchitecture also appeared exacerbated principally in ischaemic cardiomyopathy with diabetes. These findings indicate diabetes confounds the pathological phenotype in heart failure, and the need for a paradigm shift regarding lipid metabolism.